Release of arachidonic acid metabolites from isolated human alveolar type II cells.
Human alveolar type II cells are thought to play a role in the pathogenesis of lung injury. Patterns of mediator release of arachidonic acid metabolism by type II cells were therefore studied after challenge with calcium ionophore A23187, opsonized zymosan and hydrogen peroxide. A time- and concentration dependent release of cyclooxygenase products was observed, with release of PGE2 greater than 6-keto-PGF1 alpha greater than TxB2. Addition of glutathione or bicarbonate further increased the production of PGE2. N-ethylmaleimide, a sulfhydryl (SH) reactant, induced a dose-dependent increase in the release of TxB2 and 6-keto-PGF1 alpha, but not of PGE2. This relates most likely to the SH-dependency and glutathione requirement of the PGE2 isomerase and SH-independence of thromboxane and prostacyclin isomerase.
van Overveld
F J
FJ
Dept. of Respiratory Medicine, University of Antwerp (UIA), Belgium.
Jorens
P G
PG
De Backer
W A
WA
Rampart
M
M
Bossaert
L
L
Vermeire
P A
PA
D016718:Arachidonic Acid / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D002469:Cell Separation; D002478:Cells, Cultured; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D066298:In Vitro Techniques; D011650:Pulmonary Alveoli / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D015054:Zymosan / Q000494:pharmacology
D016718:Arachidonic Acid; D000001:Calcimycin; D015054:Zymosan; D006861:Hydrogen Peroxide